• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Drug List
Drug List

October 2010 - North Dakota Board of Pharmacy
October 2010 - North Dakota Board of Pharmacy

... behaviors we display? The answer should be a resounding NO! Remember, we’re all in this together, techs and RPh’s alike, working toward our common goals. I believe pharmacy technicians can, and do, offer a very special contribution to the pharmacy student’s on-site experience. It is up to us to help ...
Valsartan to losartan conversion
Valsartan to losartan conversion

... Heart Failure, Left Ventricular Dysfunction, or Both. Marc A. Pfeffer, M.D. Losartan Potassium reference guide for safe and effective use from the American Society of HealthSystem Pharmacists (AHFS DI). University of Kentucky Non-Formulary Conversion Tables (Cardiac Drugs) (Updated 09/2011, Tracy Ma ...
Sample pages 1 PDF
Sample pages 1 PDF

... and may add commercial value to marketed drugs by extending patent protection. Finally, use of controlled release technology may reduce variability of performance of drug products. The latter aspect is increasingly important given the current emphasis on “quality by design” by regulatory agencies su ...
Protocol Template Guidelines
Protocol Template Guidelines

... The introduction should open with remarks that state that this document is a clinical research protocol and the described study will be conducted in compliance with the protocol, Good Clinical Practices standards and associated Federal regulations, and all applicable University research requirements ...
Testosterone Replacement Therapy
Testosterone Replacement Therapy

INTERACTION BETWEEN GRAPEFRUIT JUICE AND DRUGS*
INTERACTION BETWEEN GRAPEFRUIT JUICE AND DRUGS*

Formulation, Development and Evaluation of delayed release
Formulation, Development and Evaluation of delayed release

... Delayed release dosage forms1 are designed to release the drug at a time rather than promptly after administration. The delay may be time based or ...
AusPAR: Regorafenib
AusPAR: Regorafenib

Efficacy and safety of a 12-week course of therapy with a new
Efficacy and safety of a 12-week course of therapy with a new

... Fluticasone distinguishes itself from other inhaled glycocorticosteroids by its high affinity with intracellular glycocorticosteroid receptor (18 times higher than dexamethasone), and its high lipophilic nature, which results in strong and long-lasting activity of the drug in the bronchi. Simultaneo ...
Generic substitution in the treatment of epilepsy
Generic substitution in the treatment of epilepsy

... Health care systems have been under increasing pressure to control the costs of prescription drugs and other services. In an effort to reduce these costs, many insurance companies strongly encourage or mandate the substitution of medications with generic preparations. As of 2006, 49 states allow gen ...
Formulation and Evaluation of sustained release Pellets of
Formulation and Evaluation of sustained release Pellets of

... The present research was engrossed on the development and evaluation of sustained release pellets of Domperidone with different grades of ethyl cellulose like ethyl cellulose N10, N7 and N20 by employing drug layering technology. Pellets were prepared and evaluated for loose bulk density, tapped bul ...
PLAN B PRODUCT MONOGRAPH
PLAN B PRODUCT MONOGRAPH

... emergency contraceptive use. Some women may experience spotting a few days after taking Plan B®. At the time of expected menses, approximately 77% of women using Plan B® had vaginal bleeding similar to their normal menses, 11-12% bled more than usual and 11% bled less than usual. The majority of wom ...
Foundation - The Learning Oasis
Foundation - The Learning Oasis

... the body and Edward Jenner invented a vaccination for smallpox after discovering the relationship between cowpox and smallpox. Each major capital city in Europe published a list of commonly used drugs. The most notable of these is the one created in Great Britain, Martindale’s Pharmacopoeia. It was ...
International Journal of Biomedical and Advance Research
International Journal of Biomedical and Advance Research

... Polymer matrix / Drug reservoir: Polymers are the backbone of TDDS, which control the release of the drug from the device. Polymer matrix can be prepared by dispersion of drug in liquid or solid state synthetic polymer base. Polymers used in TDDS should have biocompatibility and chemical compatibili ...
Pharmaceutical Administration and Regulations in Japan (2015)
Pharmaceutical Administration and Regulations in Japan (2015)

11521/16 JV/tt 1 DGD 2C Following the Council`s request to conduct
11521/16 JV/tt 1 DGD 2C Following the Council`s request to conduct

RE:Docket No.98N-0148 ;International Drug
RE:Docket No.98N-0148 ;International Drug

... in water ...
here - Patent Docs
here - Patent Docs

A Warning on Gemcitabine Generics Used For
A Warning on Gemcitabine Generics Used For

... intravenous infusion solution, leading to local adverse ...
1. Results of Operations (1) Analysis of Consolidated
1. Results of Operations (1) Analysis of Consolidated

... launch in this summer. Meanwhile, as a result of new postmarketing reports regarding serious hypersensitivity reactions, in February 2013, the company voluntarily recalled OMONTYS (a drug for treatment of anemia due to chronic kidney disease), which was launched in April 2012 in the U.S. In Europe, ...
Effect of cranberry dietary supplements with
Effect of cranberry dietary supplements with

... vitro. It may also be accounted for by differences in experimental conditions such as concentrations of cranberry juice or extracts used in those in vitro experiments. In summary, the current study has demonstrated that cranberry dietary supplements with different brands caused no significant inhibi ...
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)

... Among all, paresthesia is the most common. Paresthesia can be defined as persistent anesthesia (anesthesia well beyond the expected duration), or altered sensation (tingling or itching) well beyond the expected duration of anesthesia.3 The definition of paresthesia also includes hyperesthesia and dy ...
Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis
Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis

... The World Health Organization (WHO) estimates that 2.5% of all TB patients and 3% of all new cases are infected with MDR-TB [7, 8]; an estimated 650 000 prevalent cases of MDR-TB occurred globally in 2010 [9]. The proportions of new TB cases with MDR-TB in Eastern European countries are at alarming ...
Nanotechnology in Drug Discovery-Development and
Nanotechnology in Drug Discovery-Development and

... Phase 2 Clinical Trial • Phase 2 includes the early controlled clinical studies conducted to obtain some preliminary data on the effectiveness of the drug. • Phase 2 studies are typically well-controlled, closely monitored, and conducted in a relatively small number of patients, usually involving s ...
< 1 ... 17 18 19 20 21 22 23 24 25 ... 193 >

Biosimilar

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is a copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ""innovator"" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.Unlike the more common small-molecule drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers do not have access to the originator's molecular clone and original cell bank, nor to the exact fermentation and purification process, nor to the active drug substance. They do have access to the commercialized innovator product.Drug related authorities such as European Medicines Agency (EMA), Food and Drug Administration (FDA), and Health Canada hold their own guidance on requirements for demonstration of the similar nature of two biological products in terms of safety and efficacy. According to them, analytical studies that demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components; animal studies (including the assessment of toxicity); and a clinical study or studies (including the assessment of immunogenicity and pharmacokinetics or pharmacodynamics) that are sufficient to demonstrate safety, purity, and potency in one or more appropriate conditions of use for which the reference product is licensed and intended to be used and for which licensure is sought for the biological product.In case of a monoclonal antibody-containing medicinal product, such as Remsima, extensive physicochemical and biological characterization for it and its reference product Remicade was conducted in order to demonstrate their highly similar properties. Consequently, EMA have granted a marketing authorisation for only a few numbers of biosimilars since 2006 including a monoclonal antibody which is recently approved. Meanwhile, on March 6, 2015, the FDA approved the United States's first biosimilar product, the biosimilar filgrastim Zarxio.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report